{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:21:29Z","timestamp":1783938089513,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e33630","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:36:09Z","timestamp":1719318969000},"page":"e33630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of UPLC\u2013MS\/MS method for the simultaneous quantification of valproic acid and phenytoin in human plasma and application to study pharmacokinetic interaction in epilepsy patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Sil Thanh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duy Nguyen","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-9447","authenticated-orcid":false,"given":"Thi Anh Huynh","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen Thu Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan Kim","family":"Thi Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Van Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2148-6436","authenticated-orcid":false,"given":"Tho Vinh","family":"Minh Chau Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e33630_bib1","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.02.020405","article-title":"An estimate of the prevalence of epilepsy in Sub\u2013Saharan Africa: a systematic analysis","volume":"2","author":"Paul","year":"2012","journal-title":"Journal of global health"},{"key":"10.1016\/j.heliyon.2024.e33630_bib2","series-title":"Improving the Lives of People with Epilepsy: a Technical Brief","year":"2022"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33630_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108190","article-title":"Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33630_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33630_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e33630_bib6","article-title":"Monitoring free drug concentration: clinical usefulness and analytical","volume":"vol.71","author":"Dasgupta","year":"2016"},{"key":"10.1016\/j.heliyon.2024.e33630_bib7","series-title":"Vietnamese National Drug Formulary","year":"2018"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33630_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v11i1.1628","article-title":"Therapeutic drug monitoring of phenytoin and valproic acid in critically ill patients at Windhoek Central Hospital, Namibia","volume":"11","author":"Singu","year":"2022","journal-title":"African Journal of Laboratory Medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33630_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1309\/TE4W-938M-URP2-BMEQ","article-title":"Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase","volume":"113","author":"Dasgupta","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33630_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/FTD.0b013e318157032d","volume":"29","author":"Lancelin","year":"2007","journal-title":"Ther. Drug Monit."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e33630_bib11","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jchromb.2011.05.022","article-title":"LC\u2013MS\/MS method for simultaneous determination of valproic acid and major metabolites in human plasma","volume":"879","author":"Gao","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.heliyon.2024.e33630_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2014.11.007","article-title":"Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry","volume":"440","author":"Villanelli","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33630_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jat\/bks137","article-title":"A quantitative phenytoin GC\u2013MS method and its validation for samples from human ex situ brain microdialysis, blood and saliva using solid-phase extraction","volume":"37","author":"H\u00f6sli","year":"2013","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33630_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jat\/bkw079","article-title":"Analysis of valproic acid, salicylic acid and ibuprofen in whole blood by GC-MS","volume":"40","author":"Stephenson","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e33630_bib15","series-title":"Guidance for Industry: Bioanalytical Method Validation; FSA","year":"2018"},{"key":"10.1016\/j.heliyon.2024.e33630_bib16","series-title":"Guideline on Bioanalytical Method Validation","year":"2015"},{"key":"10.1016\/j.heliyon.2024.e33630_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpba.2017.11.042","article-title":"A rapid and simple HPLC\u2013MS\/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients","volume":"149","author":"Wen","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33630_bib18","article-title":"Development, validation, and application for simultaneous assay of metformin and sitagliptin in human plasma by liquid chromatography-tandem mass spectrometry","volume":"11","author":"Thao","year":"2020","journal-title":"Sys. Rev. Pharm."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33630_bib19","article-title":"Simultaneous liquid chromatography-tandem mass spectrometry assay of amlodipine besylate and metoprolol succinate in human plasma: development, validation, and application","volume":"10","author":"Tuyen","year":"2019","journal-title":"Sys. Rev. Pharm."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024096610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024096610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:49:13Z","timestamp":1778885353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024096610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":19,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024096610"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33630","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of UPLC\u2013MS\/MS method for the simultaneous quantification of valproic acid and phenytoin in human plasma and application to study pharmacokinetic interaction in epilepsy patients","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33630"}}